Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry. 2017

Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
University Hospital Frankfurt, Frankfurt am Main, Germany.

Chronic hepatitis C virus (HCV) infection is a leading cause for orthotopic liver transplantation (OLT) in the U.S. We investigated characteristics of HCV-infected patients registered for OLT, and explored factors associated with mortality. Data were obtained from the United Network for Organ Sharing and Organ Procurement and Transplantation network (UNOS/OPTN) registry. Analyses included 41,157 HCV-mono-infected patients ≥18 years of age listed for cadaveric OLT between February 2002 and June 2014. Characteristics associated with pre- and post-transplant survival and time trends over the study period were determined by logistic and Cox proportional hazard regression analyses and Poisson regressions. Most patients were white (69.1%) and male (70.8%). At waitlist registration, mean age was 54.6 years and mean MELD was 16. HCC was recorded in 26.9% of the records. A total of 51.2% of the patients received an OLT, 21.0% died or were too sick; 15.6% were delisted and 10.4% were still waiting. Factors associated with increased waitlist mortality were older age, female gender, blood type 0, diabetes, no HCC and transplant region (p<0.001). OLT recipient characteristics associated with increased risk for post OLT mortality were female gender, age, diabetes, race (p<0,0001), and allocation MELD (p = 0.005). Donor characteristics associated with waitlist mortality included age, ethnicity (p<0.0001) and diabetes (p<0.03). Waitlist registrations and OLTs for HCC significantly increased from 14.4% to 37.3% and 27.8% to 38.5%, respectively (p<0.0001). Pre- and post-transplant survival depended on a variety of patient-, donor-, and allocation- characteristics of which most remain relevant in the DAA-era. Still, intensified HCV screening strategies and timely and effective treatment of HCV are highly relevant to reduce the burden of HCV-related OLTs in the U.S.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009927 Tissue and Organ Procurement The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation. Organ Procurement,Organ Procurement Systems,Organ Shortage,Tissue Procurement,Tissue Shortage,Donor Cards,Organ Donation,Required Organ Donation Request,Required Request,Tissue Donation,Donor Card,Organ Donations,Organ Procurement System,Organ Procurements,Required Requests,Shortage, Tissue,Tissue Donations,Tissue Procurements,Tissue Shortages
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014850 Waiting Lists Prospective patient listings for appointments or treatments. List, Waiting,Lists, Waiting,Waiting List
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2011, Clinical transplants,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2004, Clinical transplants,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2009, Clinical transplants,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2012, Clinical transplants,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2012, Clinical transplants,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
September 2022, Transplantation,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
April 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
November 2023, Clinical transplantation,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2011, Clinical transplants,
Georg Dultz, and Barry I Graubard, and Paul Martin, and Martin-Walter Welker, and Johannes Vermehren, and Stefan Zeuzem, and Katherine A McGlynn, and Tania M Welzel
January 2009, Clinical transplants,
Copied contents to your clipboard!